MiLOOP-assisted cataract surgery for dense cataracts
Official title: EVALUATION OF MILOOP LENS FRAGMENTATION DEVICE IN PHACOEMULSIFICATION FOR DENSE CATARACTS: A RANDOMIZED CONTROLLED TRIAL
Run by Universiti Kebangsaan Malaysia Medical Centre · NCT07898007 · Data updated 2026-11-12
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | Universiti Kebangsaan Malaysia Medical Centre Academic / other |
| Locations | 1 site (Cheras, Kuala Lumpur) |
| Status | Recruiting |
| Started | October 1, 2024 |
| Main results expected | November 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07898007 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40 and older with advanced dense cataracts (LOCS III grade 4 or higher) and adequate endothelial cell counts who consent to follow-up.
✕Probably not a fit
Patients with comorbidity or ocular conditions that increase risk or those not meeting endothelial cell or compliance criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial compares two cataract surgery approaches in adults with dense nuclear sclerosis. Participants are assigned to either the miLOOP-assisted method or standard phacoemulsification, with follow-up visits to monitor vision, endothelial cell health, and safety. The study aims to see if the miLOOP device reduces endothelial cell loss, lowers energy use, and improves visual outcomes without increasing risks. Outcomes include endothelial cell density, energy usage, safety events, and postoperative vision. The trial is conducted at a single center in Malaysia and is sponsored by Universiti Kebangsaan Malaysia Medical Centre.
Why it matters
Potential benefit: If successful, patients could experience better corneal health and clearer vision after dense cataract surgery with less energy exposure.
How similar studies have gone: Previous work with lens fragmentation devices suggests potential to reduce energy use and protect the cornea, but this exact miLOOP comparison for dense cataracts is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. age 40-year-old and above 2. capable to give informed consent 3. Advanced visually significant cataract with a minimum grade 4 nuclear sclerosis based on Lens Opacities Classification System III (LOCS III) 4. Best corrected visual acuity of 6/18 or worse using Snellen visual acuity chart 5. Willingness to cooperate with the doctors in the follow-up visits Exclusion Criteria: 1. Eyes with significant anterior segment comorbidity besides an advanced cataract that could complicate the procedure including corneal opacity and zonulopathy 2. Presence of polar cataract 3. Co-existing glaucoma, cornea or retinal diseases 4. Presence of pseudoexfoliation 5. Poor pupil dilatation 6. Endothelial cell count (ECC) less than 2000 cells/mm2 7. Previous history of ocular surgery or trauma 8. History of uveitis 9. Complicated surgery such as intraoperative posterior capsule tear, zonular dialysis or conversion to extracapsular cataract extraction
Where it's running
-
Hospital Canselor Tuanku Muhriz
Cheras, Kuala Lumpur, Malaysia Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
-
Bilateral Implantation of enVista Envy Trifocal IOL for Cataract Patients
This study tests whether the enVista Envy trifocal intraocular lens can provide good distance, intermediate, and near vision after cataract surgery in adults who want less dependence on glasses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.